S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL

ABSTRACT:

SUBMITTER: Heeney M 

PROVIDER: S-EPMC8812070 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature